Chengdu Kanghua Biological Products Co., Ltd.

SZSE:300841 Stock Report

Market Cap: CN¥7.1b

Chengdu Kanghua Biological Products Valuation

Is 300841 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 300841 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 300841 (CN¥54.91) is trading below our estimate of fair value (CN¥89.84)

Significantly Below Fair Value: 300841 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300841?

Key metric: As 300841 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 300841. This is calculated by dividing 300841's market cap by their current earnings.
What is 300841's PE Ratio?
PE Ratio13.1x
EarningsCN¥546.18m
Market CapCN¥7.14b

Price to Earnings Ratio vs Peers

How does 300841's PE Ratio compare to its peers?

The above table shows the PE ratio for 300841 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average29.1x
002880 Shenzhen Weiguang Biological Products
25x13.8%CN¥6.3b
300406 Beijing Strong BiotechnologiesInc
15.5x23.2%CN¥8.2b
300685 Amoy Diagnostics
31x19.6%CN¥9.8b
600201 Jinyu Bio-technology
44.8x43.0%CN¥7.4b
300841 Chengdu Kanghua Biological Products
13.1x18.0%CN¥7.1b

Price-To-Earnings vs Peers: 300841 is good value based on its Price-To-Earnings Ratio (13.1x) compared to the peer average (29.1x).

Price to Earnings Ratio vs Industry

How does 300841's PE Ratio compare vs other companies in the CN Biotechs Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
300841 13.1xIndustry Avg. 35.5xNo. of Companies6PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 300841 is good value based on its Price-To-Earnings Ratio (13.1x) compared to the CN Biotechs industry average (37.3x).

Price to Earnings Ratio vs Fair Ratio

What is 300841's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300841 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio13.1x
Fair PE Ratio24.6x

Price-To-Earnings vs Fair Ratio: 300841 is good value based on its Price-To-Earnings Ratio (13.1x) compared to the estimated Fair Price-To-Earnings Ratio (24.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 300841 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥54.91
CN¥75.18
+36.9%
4.2%CN¥78.35CN¥72.00n/a2
Nov ’25CN¥58.67
CN¥75.18
+28.1%
4.2%CN¥78.35CN¥72.00n/a2
Oct ’25CN¥65.83
CN¥75.18
+14.2%
4.2%CN¥78.35CN¥72.00n/a2
Sep ’25CN¥51.97
CN¥75.18
+44.7%
4.2%CN¥78.35CN¥72.00n/a2
Aug ’25CN¥52.42
CN¥81.68
+55.8%
4.1%CN¥85.00CN¥78.35n/a2
Jul ’25CN¥51.68
CN¥81.68
+58.0%
4.1%CN¥85.00CN¥78.35n/a2
Jun ’25CN¥57.90
CN¥81.68
+41.1%
4.1%CN¥85.00CN¥78.35n/a2
May ’25CN¥62.82
CN¥102.01
+62.4%
16.7%CN¥119.02CN¥85.00n/a2
Apr ’25CN¥62.38
CN¥96.33
+54.4%
16.9%CN¥119.02CN¥81.97n/a3
Mar ’25CN¥62.97
CN¥84.99
+35.0%
3.5%CN¥88.00CN¥81.97n/a2
Feb ’25CN¥55.45
CN¥84.99
+53.3%
3.5%CN¥88.00CN¥81.97n/a2

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

China Resources Double-Crane PharmaceuticalLtd

CN¥21.4b

China Resources Double-Crane Pharmaceutical Co.,Ltd.

600062

CN¥20.80

7D

-3.9%

1Y

12.1%

Jiangsu Kanion PharmaceuticalLtd

CN¥8.1b

Researches and develops, produces, and sells Chinese medicines.

600557

CN¥14.29

7D

-4.2%

1Y

-23.6%

Dong-E-E-JiaoLtd

CN¥36.4b

Research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods.

423

CN¥56.60

7D

-3.0%

1Y

13.2%